Product Images Sorafenib

This is a description for Sorafenib tablets. Each film-coated tablet contains 200mg of Sorafenib, with 30 tablets per package. The tablets should be stored in a dry place, at 20°C to 25°C (68°F to 77°F), with a permitted range of 15°C to 30°C (59°F and 86°F). They should be dispensed in a tight container with a child-resistant closure and kept out of reach of children. The manufacturer is Torrent Pharmaceuticals LTD., located in Bileshwarpura-382729, India, and sold by Torrent Pharma INC., in Basking Ridge, NJ 07920.*

The text describes a clinical trial regarding Sorafenib, a medication used to treat kidney and liver cancer. The trial had 299 patients using Sorafenib tablets and 303 patients using a placebo. The median survival time of patients using Sorafenib was 10.7 months compared to 7.9 months for patients using the placebo. The Hazard Ratio (HR) was 0.69 with a P-value of 0.00058, indicating statistical significance. The text also includes a chart showing the number of patients at risk over time for Sorafenib tablets and Placebo.*

The text appears to be a survival analysis data table comparing Sorafenib tablets to Placebo treatment. The median number of days of survival for patients treated with Sorafenib is shown to be 167 days, whereas the same value for patients treated with Placebo is 84 days. The table also includes a graph depicting the progression of survival over the course of treatment.*